Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-24.94%
operating margin TTM
-30.96%
revenue TTM
264.50 Million
revenue per share TTM
4.1$
valuation ratios | |
|---|---|
| pe ratio | -77.87 |
| peg ratio | 0.56 |
| price to book ratio | 24.07 |
| price to sales ratio | 19.72 |
| enterprise value multiple | -82.31 |
| price fair value | 24.07 |
profitability ratios | |
|---|---|
| gross profit margin | 97.13% |
| operating profit margin | -30.96% |
| pretax profit margin | -24.53% |
| net profit margin | -24.94% |
| return on assets | -8.84% |
| return on equity | -33.25% |
| return on capital employed | -13.89% |
liquidity ratios | |
|---|---|
| current ratio | 2.80 |
| quick ratio | 2.75 |
| cash ratio | 0.49 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 388.13 |
| operating cycle | 456.84 |
| days of payables outstanding | 23.97 |
| cash conversion cycle | 432.86 |
| receivables turnover | 5.31 |
| payables turnover | 15.23 |
| inventory turnover | 0.94 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.10 |
| debt equity ratio | 0.36 |
| long term debt to capitalization | 0.16 |
| total debt to capitalization | 0.26 |
| interest coverage | -2.91 |
| cash flow to debt ratio | -0.79 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.58 |
| cash per share | 9.06 |
| operating cash flow per share | -1.53 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -0.79 |
| short term coverage ratios | -1.69 |
| capital expenditure coverage ratio | -34.96 |
Frequently Asked Questions
When was the last time Blueprint Medicines Corporation (NASDAQ:BPMC) reported earnings?
Blueprint Medicines Corporation (BPMC) published its most recent earnings results on 01-05-2025.
What is Blueprint Medicines Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Blueprint Medicines Corporation (NASDAQ:BPMC)'s trailing twelve months ROE is -33.25%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Blueprint Medicines Corporation (BPMC) currently has a ROA of -8.84%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BPMC's net profit margin stand at?
BPMC reported a profit margin of -24.94% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BPMC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.80 in the most recent quarter. The quick ratio stood at 2.75, with a Debt/Eq ratio of 0.36.